Silvan Turkcan
Stock Analyst at Citizens
(1.91)
# 3,219
Out of 5,146 analysts
1
Total ratings
100%
Success rate
5.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Silvan Turkcan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Market Outperform | $86 → $80 | $55.20 | +44.93% | 1 | Jan 30, 2026 |
CRISPR Therapeutics AG
Jan 30, 2026
Maintains: Market Outperform
Price Target: $86 → $80
Current: $55.20
Upside: +44.93%